Crossmark

Identification of population characteristics through implementation of the Comprehensive Diabetic Retinopathy Program

Crossref DOI link: https://doi.org/10.1186/s40842-019-0079-6

Published Online: 2019-05-09

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Patel, Nish

Verchinina, Lilia

Wichorek, Michele

Gardner, Thomas W.

Markel, Dorene

Wyckoff, Jennifer

Shah, Anjali R. https://orcid.org/0000-0001-6440-423X
Funding

Funding for this research was provided by:

A. Alfred Taubman Medical Research Institute

Research to Prevent Blindness (n/a)
License Information

Text and Data Mining valid from 2019-05-09
More Information

Article History

Received: 16 October 2018

Accepted: 28 April 2019

First Online: 9 May 2019

Ethics approval and consent to participate

: Study was IRB-exempt by the University of Michigan Institutional Review Board (application filed).

: Not applicable.

: T.W.G. is a consultant for Novo Nordisk and receives research funding from Zebra Biologics.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.